Medications

Unituxin approved for deadly pediatric cancer

(HealthDay)—Unituxin (dinutuximab) has been approved by the U.S. Food and Drug Administration to treat children with high-risk neuroblastoma, a rare cancer that most often affects children aged five and under.

Surgery

Protecting nerve tissue during bowel surgery

After bowel surgery, more than half of the patients suffer from irreparable nerve damage. Now scientists have developed an assistance system that warns surgeons about the risk of inflicting possible injury during operations ...

Medical research

Study shows potential new therapy for neuropathic pain

An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat ...

Neuroscience

New drug target for multiple sclerosis discovered

Scientists at the Centre for Addiction and Mental Health (CAMH) have discovered a promising new approach to treat multiple sclerosis (MS). In a new study, they've identified a previously unknown change in the spinal cord ...

Diseases, Conditions, Syndromes

Leprosy still occurs in US, CDC reports

(HealthDay)—Leprosy, although quite rare, continues to appear in the United States, a new U.S. government study reports.

page 16 from 26